1-3 of 3
Herman Van Besien
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Metabolic Vulnerabilities in Primary Effusion Lymphoma Using the Novel Nucleoside Analog 6-Eti

Jouliana Sadek, Jan Krumsiek, Tuo Zhang, Barbara Coan, Maite Ibañez de Garayo, Tanner Dalton, Sara Yahyaei, Herman Van Besien, Ethel Cesarman
Journal: Blood
Blood (2021) 138 (Supplement 1): 1188.
https://doi.org/10.1182/blood-2021-153670
Published: 2021
Journal Articles

Combined EZH2 and BCL2 Inhibitors As Precision Therapy for Genetically Defined DLBCL Subtypes

Destini Gibbs, Herman Van Besien, BA, Stephenson Regan, Ankur Singh, PhD, Matthew Teater, Ethel Cesarman, MD PhD, Ari Melnick, MD, Lisa Giulino Roth, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 304.
https://doi.org/10.1182/blood-2019-126790
Published: 2019
Journal Articles

Targeting the Hsp90 Oncoproteome in Burkitt Lymphoma

Lisa Giulino Roth, MD, Herman van Besien, Anna Rodina, PhD, Tony Taldone, PhD, Hediye Erdjument-Bromage, PhD, Matthew J. Barth, MD, Gabriela Chiosis, PhD, Ethel Cesarman
Journal: Blood
Blood (2015) 126 (23): 592.
https://doi.org/10.1182/blood.V126.23.592.592
Published: 2015